Insiders · NGNE

Stuart Cobb

Chief Scientific Officer at Neurogene Inc. (NGNE) since December 2023

Stuart Cobb has filed 6 insider reports with the SEC since December 2023, as chief Scientific Officer at Neurogene Inc. (NGNE). In the last 12 months Stuart Cobb sold $141K of stock on the open market. In the latest filing, on March 17, 2026, Stuart Cobb sold 6,797 shares of Neurogene Inc. (NGNE) for $141K at an average of $20.81.

Filings
6
Companies
1
Bought on market
None
Sold on market
$244K

Companies where Stuart Cobb is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Neurogene Inc. logo
NGNE
Neurogene Inc.
Chief Scientific Officersince December 202330,497$244K$22.15Mar 17, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Stuart Cobb with

Other insiders at the same companies

Questions about Stuart Cobb

What is Stuart Cobb's role at Neurogene Inc.?
Stuart Cobb reports to the SEC as chief Scientific Officer at Neurogene Inc. (NGNE), according to the latest filing on March 17, 2026.
How many shares does Stuart Cobb own?
After the latest filing that states it, Stuart Cobb directly owned 30,497 shares of Neurogene Inc. (NGNE). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Stuart Cobb bought or sold stock recently?
The most recent open-market sale was on March 13, 2026: sold 6,797 shares of Neurogene Inc. (NGNE) for $141K at an average of $20.81.
How do I get alerts when Stuart Cobb files?
Follow Stuart Cobb on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Stuart Cobb (SEC CIK 0001994301). Totals count each trade once, skipping amendments whose original is on file, from Dec 26, 2023 on. View on SEC EDGAR · Get this as JSON